Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Ethnopharmacological Relevance: Ashwagandha (Withania somnifera (L.) Dunal) root or whole-plant extracts are used to treat anxiety, insomnia, and other nervous system disturbances.

Aim Of The Study: We evaluated the neuroprotective and antidepressant effects of ashwagandha root extract (ARE) on corticosterone-exposed HT-22 cells and unpredictable chronic mild stress (UCMS)-challenged mice.

Materials And Methods: The neuroprotective properties of ARE containing withanolide A were assessed in HT-22 cells subjected to corticosterone-induced oxidative stress. Additionally, the effects of ARE on depression-like behavior, stress-related hormones, and inflammatory cytokine levels were evaluated in a mouse model of UCMS.

Results: In HT-22 cells, ARE (100 and 200 μg/mL) and its constituent, withanolide A (1.56 and 3.12 μg/mL), mitigated corticosterone-induced increases in MAO activity, ROS, and MDA levels. Treatment also reversed corticosterone-induced reductions in BDNF, TrkB, p-AKT, p-ERK, and p-CREB and normalized Nrf2 and Keap1 levels, thereby elevating HO-1 expression. In UCMS mice, ARE improved behavioral outcomes, increased sucrose preference, and reduced immobility in the forced swimming test while enhancing activity in the open field test and elevated plus maze. ARE decreased the levels of stress hormones (corticotropin-releasing hormone, adrenocorticotropic hormone, and corticosterone) and increased the levels of neurotransmitters (L-DOPA, 5-HTP, and serotonin). Histological analysis revealed that ARE reduced hippocampal cell loss. Additionally, ARE (60 and 100 mg/kg) restored decreased levels of p-AKT, p-ERK, and p-CREB and lowered inflammation-related proteins (Cox2, iNOS, IL-6, IL-1β, TNF-α).

Conclusion: These results indicate that ARE containing withanolide A exhibits notable neuroprotective and antidepressant properties.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jep.2024.119224DOI Listing

Publication Analysis

Top Keywords

ashwagandha withania
8
withania somnifera
8
somnifera dunal
8
dunal root
8
root extract
8
depression-like behavior
8
chronic mild
8
mild stress
8
neuroprotective antidepressant
8
p-akt p-erk
8

Similar Publications

Ashwagandha (Withania somnifera), a revered herb in Ayurvedic medicine, has gained significant scientific recognition for its potential to promote healthy aging. Traditionally used as a Rasayana or rejuvenator, this potent adaptogen helps the body manage stress and enhance vitality. This review synthesises extensive evidence for its multifaceted anti-aging capabilities, which target key hallmarks of the aging process.

View Article and Find Full Text PDF

Anemia remains a widespread public health concern, and the search for interventions demonstrating potent anti-anemic activity is critical for reducing its impact among high-risk populations. Conventional iron therapies are associated with several complications and potential adverse effects. This study explored a polyherbal approach to develop a safer and more effective alternative treatment for anemia.

View Article and Find Full Text PDF

Ashwagandha (Withania somnifera) is a widely used herbal supplement with established adaptogenic and neuroprotective properties. Although generally considered safe, rare adverse neurological effects may occur. We present the case of a previously healthy adult male who developed acute-onset dystonia following the initiation of Ashwagandha supplementation.

View Article and Find Full Text PDF

Withania somnifera (L.) Dunal, commonly known as ashwagandha, has been widely used in Ayurvedic medicine for its adaptogenic properties and therapeutic potential and has been investigated for its benefits related to sleep and stress management by Western medicine. However, concerns regarding its teratogenic and abortifacient effects have emerged following reports from the World Health Organization (WHO) and regulatory bodies.

View Article and Find Full Text PDF

: Parkinson's disease (PD) is a complex nervous system disorder characterized by the gradual loss of dopaminergic neurons, leading to disturbances in movement, such as resting tremors, rigidity, bradykinesia, or akinesia; postural issues; and freezing (motor block). Due to the limitations and side effects of current pharmacological treatments, there is a growing interest in investigating the therapeutic potential of medicinal plants. : A semi-systematic review was conducted using PubMed, Web of Science, and Scopus as main databases, identifying original research articles, systematic reviews, and relevant preclinical or clinical studies published between January 2000 and December 2024.

View Article and Find Full Text PDF